Novel antitubercular agents based on 2,4-disubstituted 5-(aryl-2-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidines.
Finger V, Vrbicky M, Muckova L, Prchal L, Novak M, Marek J, Soukup O, Hympanova M, Sorf A, Benkova M, Bartacek J, Drabina P, Kufa M, Kovar O, Fikejzlová L, Hruby M, Ozhelevska O, Jagob J, Zdarova-Karasova J, Odvarkova J, Kaderavková I, Rozsypal T, Ewa Greber K, Ciura K, Janousek J, Kratky M, Igreja Sa IC, Bostik P, Sleha R, Roh J, Korabecny J.
Finger V, et al. Among authors: janousek j.
Biomed Pharmacother. 2025 Oct;191:118537. doi: 10.1016/j.biopha.2025.118537. Epub 2025 Sep 12.
Biomed Pharmacother. 2025.
PMID: 40945271
Free article.